INS and type 2 diabetes mellitus: It was reported that INCB013739 treatment of type 2 diabetes mellitus patients who failed on metformin monotherapy could significantly improve hepatic and peripheral insulin sensitivity and reduce haemoglobin A1c and fasting plasma glucose.